We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
-1.98%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$2.85B
AUM Growth
+$102M
Cap. Flow
+$208M
Cap. Flow %
7.28%
Top 10 Hldgs %
21.68%
Holding
535
New
168
Increased
71
Reduced
85
Closed
189

Top Buys

Rank Stock Value
1
SN icon
SharkNinja
SN
+$75.8M
2
DIS icon
Walt Disney
DIS
+$62.3M
3
KVUE icon
Kenvue
KVUE
+$55.7M
4
TGT icon
Target
TGT
+$51.2M
5
SMH icon
VanEck Semiconductor ETF
SMH
+$38.5M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$47.9M
2
VFC icon
VF Corp
VFC
+$40.9M
3
SPLK
Splunk Inc
SPLK
+$36.3M
4
BA icon
Boeing
BA
+$30.1M
5
JNJ icon
Johnson & Johnson
JNJ
+$26.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.36%
2 Technology 13.19%
3 Healthcare 9.24%
4 Industrials 8.98%
5 Communication Services 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGIO icon
301
CALL
Agios Pharmaceuticals
AGIO
$1.82B
$334K 0.01%
13,500
-6,800
-33% -$180K
IFRX icon
302
InflaRx
IFRX
$258M
$322K 0.01%
108,001
-204,141
-65% -$777K
UPWK icon
303
Upwork
UPWK
$1.18B
$315K 0.01%
+27,750
New +$344K
TRVI icon
304
Trevi Therapeutics
TRVI
$2.54B
$301K 0.01%
137,873
BNTX icon
305
BioNTech
BNTX
$23.3B
$293K 0.01%
2,700
RRR icon
306
Red Rock Resorts
RRR
$3.84B
$278K 0.01%
+6,771
New +$306K
TEVA icon
307
Teva Pharmaceuticals
TEVA
$40.2B
$275K 0.01%
27,000
-715,500
-96% -$6.66M
IOVA icon
308
PUT
Iovance Biotherapeutics
IOVA
$1.93B
$246K 0.01%
+54,000
New +$353K
AZO icon
309
AutoZone
AZO
$48.8B
$244K 0.01%
+96
New +$241K
NU icon
310
Nu Holdings
NU
$69.8B
$236K 0.01%
+32,550
New +$244K
UDMY
311
PUT
DELISTED
Udemy
UDMY
$235K 0.01%
+24,700
New +$258K
RH icon
312
RH
RH
$3.29B
$234K 0.01%
+884
New +$307K
EWD icon
313
iShares MSCI Sweden ETF
EWD
$584M
$231K 0.01%
7,000
-1,750
-20% -$59.6K
RAPT
314
CALL
DELISTED
RAPT Therapeutics
RAPT
$224K 0.01%
+1,688
New +$276K
NPWR.WS icon
315
CALL
NET Power Inc Warrants
NPWR.WS
$16.1M
$223K 0.01%
51,706
-48,745
-49% -$190K
LRMR icon
316
Larimar Therapeutics
LRMR
$413M
$213K 0.01%
54,000
DPZ icon
317
Domino's
DPZ
$12.1B
$203K 0.01%
+536
New +$206K
BABA icon
318
CALL
Alibaba
BABA
$305B
$191K 0.01%
+2,200
New +$201K
GNE icon
319
Genie Energy
GNE
$373M
$183K 0.01%
12,423
ALDX icon
320
Aldeyra Therapeutics
ALDX
$92.3M
$180K 0.01%
27,000
-81,000
-75% -$601K
NCEL
321
NewcelX Ltd
NCEL
$18.4M
$178K 0.01%
637
+126
+25% +$45.3K
KPTI icon
322
Karyopharm Therapeutics
KPTI
$44.6M
$161K 0.01%
8,000
-27,983
-78% -$628K
LZM.WS icon
323
CALL
Lifezone Metals Ltd Warrants
LZM.WS
$21.4M
$160K 0.01%
+136,469
New +$118K
CPRX
324
DELISTED
Catalyst Pharmaceutical
CPRX
$158K 0.01%
13,500
-513,202
-97% -$6.86M
WBD icon
325
Warner Bros
WBD
$65.4B
$136K ﹤0.01%
+12,500
New +$156K

Similar funds

J. Goldman & Co's Q3 2023 Portfolio in Review

As of Q3 2023, J. Goldman & Co held 535 positions worth $2.85B, up 3.7% from $2.75B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

J. Goldman & Co deployed $208M of net new capital in Q3 2023, opening 168 new positions and adding to 71 existing holdings. Its largest new stake was SharkNinja: 2,071,888 shares worth $96.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $47.9M trimmed.

  • J. Goldman & Co's largest Q3 2023 buy was SharkNinja: 2,071,888 shares worth $96.1M.
  • J. Goldman & Co added most to PayPal in Q3 2023, an estimated $34.3M increase.
  • J. Goldman & Co's biggest Q3 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $47.9M.
  • J. Goldman & Co fully exited VF Corp in Q3 2023, selling an estimated $40.9M.
  • J. Goldman & Co's ten largest holdings make up 22% of its $2.85B portfolio in Q3 2023.
  • J. Goldman & Co opened 168 new positions and closed 189 in Q3 2023.
  • J. Goldman & Co's portfolio value rose 3.7% quarter-over-quarter to $2.85B.

Based on J. Goldman & Co's 13F filing for Q3 2023, filed 14 Nov 2023.